WHO ICTRP trial
Construction and validation of a risk prediction model for unplanned readmission…
ChiCTR2500106184 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500106184 |
|---|---|
| Public title | Construction and validation of a risk prediction model for unplanned readmission of type 2 diabetes patients in primary medical institutions |
| Scientific title | Based on the chronic disease management platform, the blood glucose control level of patients with type 2 diabetes and the construction of a readmission prediction model were investigated |
| Primary sponsor | Luoyang Central Hospital Affiliated to Zhengzhou University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Type 2 diabetes |
| Interventions | Readmission group for type 2 diabetes:None;The group of type 2 diabetes patients who were not readmitted:None |
| Registration date | Jul 18, 2025 |
| Target size | Readmission group for type 2 diabetes:500;The group of type 2 diabetes patients… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: